MGNX – Macrogenics Inc
MacroGenics, Inc.MGNX
$1.72Name : MacroGenics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $108,804,680.00
EPSttm : -1.21
MacroGenics, Inc.
$1.72
0.58%$0.01Float Short %
7.14
Margin Of Safety %
Put/Call OI Ratio
0.07
EPS Next Q Diff
-0.92
EPS Last/This Y
0.19
EPS This/Next Y
-0.83
Price
1.71
Target Price
4
Analyst Recom
2.17
Performance Q
20.28
Relative Volume
0.24
Beta
1.48
Ticker: MGNX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-01-13 | MGNX | 1.75 | 0.09 | 0.00 | 3269 |
| 2026-01-14 | MGNX | 1.79 | 0.09 | 0.00 | 3269 |
| 2026-01-15 | MGNX | 1.71 | 0.08 | 0.00 | 3448 |
| 2026-01-16 | MGNX | 1.73 | 0.08 | 0.00 | 3462 |
| 2026-01-20 | MGNX | 1.75 | 0.08 | 0.00 | 1828 |
| 2026-01-21 | MGNX | 1.745 | 0.07 | 0.00 | 1878 |
| 2026-01-22 | MGNX | 1.765 | 0.07 | 0.00 | 1888 |
| 2026-01-23 | MGNX | 1.81 | 0.07 | 0.00 | 1893 |
| 2026-01-26 | MGNX | 1.83 | 0.07 | 0.00 | 1893 |
| 2026-01-27 | MGNX | 1.84 | 0.07 | 0.00 | 1906 |
| 2026-01-28 | MGNX | 1.805 | 0.07 | 0.00 | 1909 |
| 2026-01-29 | MGNX | 1.94 | 0.07 | 0.00 | 1911 |
| 2026-01-30 | MGNX | 1.83 | 0.07 | 0.00 | 1935 |
| 2026-02-02 | MGNX | 1.755 | 0.07 | 0.00 | 1933 |
| 2026-02-03 | MGNX | 1.75 | 0.07 | 0.00 | 1933 |
| 2026-02-04 | MGNX | 1.715 | 0.07 | 0.00 | 1933 |
| 2026-02-05 | MGNX | 1.7 | 0.07 | 0.00 | 1934 |
| 2026-02-06 | MGNX | 1.81 | 0.07 | 0.00 | 1934 |
| 2026-02-09 | MGNX | 1.805 | 0.07 | 0.00 | 1934 |
| 2026-02-10 | MGNX | 1.72 | 0.07 | 0.00 | 1934 |
| 2026-02-11 | MGNX | 1.715 | 0.07 | 0.00 | 1934 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-01-13 | MGNX | 1.75 | 97.6 | - | -0.89 |
| 2026-01-14 | MGNX | 1.79 | 97.6 | - | -0.89 |
| 2026-01-15 | MGNX | 1.71 | 97.6 | - | -0.89 |
| 2026-01-16 | MGNX | 1.73 | 97.6 | - | -0.89 |
| 2026-01-20 | MGNX | 1.75 | 97.6 | - | -0.89 |
| 2026-01-21 | MGNX | 1.75 | 97.6 | - | -0.89 |
| 2026-01-22 | MGNX | 1.76 | 97.6 | - | -0.89 |
| 2026-01-23 | MGNX | 1.81 | 97.6 | - | -0.89 |
| 2026-01-26 | MGNX | 1.83 | 97.6 | - | -0.89 |
| 2026-01-27 | MGNX | 1.84 | 97.6 | - | -0.89 |
| 2026-01-28 | MGNX | 1.80 | 97.6 | - | -0.89 |
| 2026-01-29 | MGNX | 1.94 | 97.6 | - | -0.89 |
| 2026-01-30 | MGNX | 1.83 | 97.6 | - | -0.89 |
| 2026-02-02 | MGNX | 1.75 | 97.6 | - | -0.89 |
| 2026-02-03 | MGNX | 1.75 | 97.6 | - | -0.89 |
| 2026-02-04 | MGNX | 1.72 | 97.6 | - | -0.89 |
| 2026-02-05 | MGNX | 1.70 | 97.6 | - | -0.89 |
| 2026-02-06 | MGNX | 1.81 | 97.6 | - | -0.89 |
| 2026-02-09 | MGNX | 1.81 | 97.6 | - | -0.89 |
| 2026-02-10 | MGNX | 1.72 | 97.6 | - | -0.89 |
| 2026-02-11 | MGNX | 1.71 | 97.6 | - | -0.89 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-01-13 | MGNX | 2.00 | -16.97 | 6.72 |
| 2026-01-14 | MGNX | 2.00 | -16.97 | 6.72 |
| 2026-01-15 | MGNX | 2.00 | -16.97 | 6.72 |
| 2026-01-16 | MGNX | 2.00 | -16.97 | 6.72 |
| 2026-01-20 | MGNX | 2.00 | -16.14 | 6.72 |
| 2026-01-21 | MGNX | 2.00 | -16.14 | 6.72 |
| 2026-01-22 | MGNX | 2.00 | -16.14 | 6.72 |
| 2026-01-23 | MGNX | 2.00 | -16.14 | 6.72 |
| 2026-01-26 | MGNX | 2.00 | -16.16 | 6.72 |
| 2026-01-27 | MGNX | 2.00 | -16.16 | 6.72 |
| 2026-01-28 | MGNX | 2.00 | -16.16 | 6.95 |
| 2026-01-29 | MGNX | 2.00 | -16.16 | 6.95 |
| 2026-01-30 | MGNX | 2.00 | -16.16 | 6.95 |
| 2026-02-02 | MGNX | 2.00 | -16.48 | 6.95 |
| 2026-02-03 | MGNX | 2.00 | -16.48 | 6.95 |
| 2026-02-04 | MGNX | 2.00 | -16.48 | 6.95 |
| 2026-02-05 | MGNX | 2.00 | -16.48 | 6.95 |
| 2026-02-06 | MGNX | 2.00 | -16.48 | 6.95 |
| 2026-02-10 | MGNX | 2.00 | -16.19 | 6.95 |
| 2026-02-11 | MGNX | 2.00 | -16.19 | 7.14 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.27
Avg. EPS Est. Current Quarter
-0.02
Avg. EPS Est. Next Quarter
-0.66
Insider Transactions
2
Institutional Transactions
-16.19
Beta
1.48
Average Sales Estimate Current Quarter
27
Average Sales Estimate Next Quarter
9
Fair Value
Quality Score
36
Growth Score
24
Sentiment Score
22
Actual DrawDown %
95.3
Max Drawdown 5-Year %
-97
Target Price
4
P/E
Forward P/E
PEG
P/S
0.85
P/B
1.62
P/Free Cash Flow
EPS
-1.21
Average EPS Est. Cur. Y
-0.89
EPS Next Y. (Est.)
-1.72
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-59.46
Relative Volume
0.24
Return on Equity vs Sector %
-141.1
Return on Equity vs Industry %
-124.8
EPS 1 7Days Diff
1.3
EPS 1 30Days Diff
0.83
EBIT Estimation
MacroGenics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 341
MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule for the treatment of solid tumors, which is in preclinical trials. It is also developing next generation T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland.
stock quote shares MGNX – Macrogenics Inc Stock Price stock today
news today MGNX – Macrogenics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MGNX – Macrogenics Inc yahoo finance google finance
stock history MGNX – Macrogenics Inc invest stock market
stock prices MGNX premarket after hours
ticker MGNX fair value insiders trading